Industry supported Symposia
Industry supported symposia will be hosted within the ICC, with a maximum of two symposia running concurrently on the following dates:
| Date: | Tuesday, 23 April |
| Time: | 17.30 including catering |
| Organiser: | Roche |
| Title: | Challenging Expectations in RA Outcomes: Disease remission is achievable for patients on therapy without Methotrexate |
| Location: | Hall 5 |
| Date: | Wednesday, 24 April |
| Time: | 07.00 including catering |
| Organiser: | Actelion |
| Title: | Digital Ulcers (DU) as a complication of Systemic Scleroderma (SSc): Management and prevention strategies and the importance of measuring outcomes |
| Aim: | To provide delegates with up-to-date information on management strategies for DU patients and to discuss the importance of measuring outcomes in treatment success |
| Location: | Hall 8 |
| Date: | Wednesday, 24 April |
| Time: | 07.00 including catering |
| Organiser: | Pfizer |
| Title: | Modern management of rheumatoid arthritis: is it a game of two halves? |
| Location: | Hall 5 |
| Date: | Wednesday, 24 April |
| Time: | 17.30 including catering |
| Organiser: | AbbVie |
| Title: | Introducing A Targeted Ultrasound Initiative: New Standards for Assessment in RA |
| Aim: | To provide delegates with an overview of the key advances in ultrasound in the management of rheumatoid arthritis using Treat to target principles |
| Location: | Hall 5 |
| Date: | Thursday, 25 April |
| Time: | 07.00 including catering |
| Organiser: | Bristol-Myers Squibb |
| Title: | Getting it right first time - Biologics in RA; a debate |
| Aim: | Rheumatologistsand allied health professionals managing Rheumatoid Arthritis (RA) have an ever expanding range of treatment options available for treatment of RA, however it can be challenging to ensure that these therapies are used in a way that offers the best patient outcomes |
| Location: | Hall 5 |
